摘要
目的 :随着环境的污染和致炎物质的侵袭 ,近年来 ,哮喘和慢性阻塞性肺病已成为重要的社会公共问题 ,在其治疗中 ,β2受体激动剂作用于小气道 ,通过兴奋 β2 受体而松弛支气管平滑肌 ,增强肾上腺皮质激素受体的移位。本文则旨在回顾此类药物的进展和临床评价。方法 :检索和采用中、外文献的综述方式。结果与结论 :选择性 β2 受体激动剂疗效确切 ,对受体选择性高 ,在治疗支气管哮喘、气管炎、慢性阻塞性肺病上显示了良好的前景。
OBJECTIVE:With environmental pollution and invasion of the inflammation induced by some materials, asthma and chronic obstructive pulmonary disease(COPD)have become the important social public problems in recent years. During the treatment,β 2 receptor agonist acts on the small airway,by stimulating β 2 receptor to relax tracheal smooth muscle and strengthen ACH receptor displacement. This paper is to review the progress and clinical evaluation of this kind of drugs. METHODS: The common and new proton pump inhibitors were analyzed and discussed by the way of reviewing medical literatures in recent years at home and abroad. RESULTS & CONCLUSION: Selected β 2 receptor agonist has confirmed curative effect, which has high selection to the receptor. It has bright future for the treatment of bronchia asthma, bronchitis and COPD.
出处
《中国医院用药评价与分析》
2004年第5期265-268,共4页
Evaluation and Analysis of Drug-use in Hospitals of China
